Cargando…

Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study

BACKGROUND: Research on the duration of infectivity of ICU patients with COVID-19 has been sparse. Tests based on Reverse Transcriptase polymerase chain reaction (RT-PCR) detect both live virus and non-infectious viral RNA. We aimed to determine the duration of infectiousness based on viral culture...

Descripción completa

Detalles Bibliográficos
Autores principales: Funk, Duane J., Bullard, Jared, Lother, Sylvan, Grande, Gloria Vazquez, Garnett, Lauren, Doan, Kaylie, Dust, Kerry, Kumar, Anand, Poliquin, Guillaume, Strong, Jim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724747/
https://www.ncbi.nlm.nih.gov/pubmed/34983614
http://dx.doi.org/10.1186/s13054-021-03884-z
_version_ 1784625975044079616
author Funk, Duane J.
Bullard, Jared
Lother, Sylvan
Grande, Gloria Vazquez
Garnett, Lauren
Doan, Kaylie
Dust, Kerry
Kumar, Anand
Poliquin, Guillaume
Strong, Jim
author_facet Funk, Duane J.
Bullard, Jared
Lother, Sylvan
Grande, Gloria Vazquez
Garnett, Lauren
Doan, Kaylie
Dust, Kerry
Kumar, Anand
Poliquin, Guillaume
Strong, Jim
author_sort Funk, Duane J.
collection PubMed
description BACKGROUND: Research on the duration of infectivity of ICU patients with COVID-19 has been sparse. Tests based on Reverse Transcriptase polymerase chain reaction (RT-PCR) detect both live virus and non-infectious viral RNA. We aimed to determine the duration of infectiousness based on viral culture of nasopharyngeal samples of patients with COVID-19. METHODS: Prospective observational study in adult intensive care units with a diagnosis of COVID-19 Pneumonia. Patients had repeated nasopharyngeal sampling performed after day 10 of ICU admission. Culture positive rate (based on viral culture on Vero cells in a level 4 lab) and Cycle threshold from RT-PCR were measured. RESULTS: Nine patients of the 108 samples (8.3%, 95% CI 3.9–15.2%) grew live virus at a median of 13 days (interquartile range 11–19) after their initial positive test. 74.1% of patients were RT-PCR positive but culture negative, and the remaining (17.6%) were RT-PCR and culture negative. Cycle threshold showed excellent ability to predict the presence of live virus, with a Ct < 25 with an AUC of 0.90 (95% CI 0.83–0.97, p < 0.001). The specificity of a Ct > 25 to predict negative viral culture was 100% (95% CI 70–100%). CONCLUSION: 8.3% of our ICU patients with COVID-19 grew live virus at a median of 13 days post-initial positive RT-PCR test. Severity of illness, use of mechanical ventilation, and time between tests did not predict the presence of live virus. Cycle threshold of > 25 had the best ability to determine the lack of live virus in these patents.
format Online
Article
Text
id pubmed-8724747
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87247472022-01-04 Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study Funk, Duane J. Bullard, Jared Lother, Sylvan Grande, Gloria Vazquez Garnett, Lauren Doan, Kaylie Dust, Kerry Kumar, Anand Poliquin, Guillaume Strong, Jim Crit Care Research BACKGROUND: Research on the duration of infectivity of ICU patients with COVID-19 has been sparse. Tests based on Reverse Transcriptase polymerase chain reaction (RT-PCR) detect both live virus and non-infectious viral RNA. We aimed to determine the duration of infectiousness based on viral culture of nasopharyngeal samples of patients with COVID-19. METHODS: Prospective observational study in adult intensive care units with a diagnosis of COVID-19 Pneumonia. Patients had repeated nasopharyngeal sampling performed after day 10 of ICU admission. Culture positive rate (based on viral culture on Vero cells in a level 4 lab) and Cycle threshold from RT-PCR were measured. RESULTS: Nine patients of the 108 samples (8.3%, 95% CI 3.9–15.2%) grew live virus at a median of 13 days (interquartile range 11–19) after their initial positive test. 74.1% of patients were RT-PCR positive but culture negative, and the remaining (17.6%) were RT-PCR and culture negative. Cycle threshold showed excellent ability to predict the presence of live virus, with a Ct < 25 with an AUC of 0.90 (95% CI 0.83–0.97, p < 0.001). The specificity of a Ct > 25 to predict negative viral culture was 100% (95% CI 70–100%). CONCLUSION: 8.3% of our ICU patients with COVID-19 grew live virus at a median of 13 days post-initial positive RT-PCR test. Severity of illness, use of mechanical ventilation, and time between tests did not predict the presence of live virus. Cycle threshold of > 25 had the best ability to determine the lack of live virus in these patents. BioMed Central 2022-01-04 /pmc/articles/PMC8724747/ /pubmed/34983614 http://dx.doi.org/10.1186/s13054-021-03884-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Funk, Duane J.
Bullard, Jared
Lother, Sylvan
Grande, Gloria Vazquez
Garnett, Lauren
Doan, Kaylie
Dust, Kerry
Kumar, Anand
Poliquin, Guillaume
Strong, Jim
Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study
title Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study
title_full Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study
title_fullStr Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study
title_full_unstemmed Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study
title_short Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study
title_sort persistence of live virus in critically ill patients infected with sars-cov-2: a prospective observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724747/
https://www.ncbi.nlm.nih.gov/pubmed/34983614
http://dx.doi.org/10.1186/s13054-021-03884-z
work_keys_str_mv AT funkduanej persistenceoflivevirusincriticallyillpatientsinfectedwithsarscov2aprospectiveobservationalstudy
AT bullardjared persistenceoflivevirusincriticallyillpatientsinfectedwithsarscov2aprospectiveobservationalstudy
AT lothersylvan persistenceoflivevirusincriticallyillpatientsinfectedwithsarscov2aprospectiveobservationalstudy
AT grandegloriavazquez persistenceoflivevirusincriticallyillpatientsinfectedwithsarscov2aprospectiveobservationalstudy
AT garnettlauren persistenceoflivevirusincriticallyillpatientsinfectedwithsarscov2aprospectiveobservationalstudy
AT doankaylie persistenceoflivevirusincriticallyillpatientsinfectedwithsarscov2aprospectiveobservationalstudy
AT dustkerry persistenceoflivevirusincriticallyillpatientsinfectedwithsarscov2aprospectiveobservationalstudy
AT kumaranand persistenceoflivevirusincriticallyillpatientsinfectedwithsarscov2aprospectiveobservationalstudy
AT poliquinguillaume persistenceoflivevirusincriticallyillpatientsinfectedwithsarscov2aprospectiveobservationalstudy
AT strongjim persistenceoflivevirusincriticallyillpatientsinfectedwithsarscov2aprospectiveobservationalstudy